A Study of the Safety, Dosing, and Delivery of NEO100 in Patients With Pediatric Brain Tumors

Conditions: Pediatric Tumor of CNS; Pediatric Tumor of Brain; Diffuse Midline Glioma, H3 K27M-Mutant; Pediatric Tumor of Brain Stem; Pineocytoma; Choroid Plexus Carcinoma, Childhood; Spinal Cord Tumor; High Grade Glioma Interventions: Drug: NEO100 Sponsors: Neonc Technologies, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials